Early Neurovascular Adaptations in Aging Women
Early Phase 1
Recruiting
- Conditions
- AgingWomenBlood FlowSympathetic Nervous System
- Interventions
- Registration Number
- NCT06520982
- Lead Sponsor
- University of Missouri-Columbia
- Brief Summary
Our goal is to enhance our understanding of early vascular adaptations in aging women with an emphasis on the sympathetic nervous system.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 64
Inclusion Criteria
- Assigned female at birth (AFAB)
- 18-55 years of age
Exclusion Criteria
- Assigned male at birth (AMAB)
- Pregnancy, breastfeeding
- Body mass index ≥30 kg/m2
- Taking medications known to affect metabolic, autonomic, and/or respiratory function
- Oral hormonal contraception in last 6 month
- History of hormone replacement therapy
- History of hyster- or oophor-ectomy
- Current smoking/Nicotine use
- Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy
- Chronic disease
- Blood pressure ≥140/90 mmHg
- Communication barriers
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Women Norepinephrine Women will be 18-55 years of age Women Isoproterenol Women will be 18-55 years of age Women Acetylcholine Women will be 18-55 years of age Women Nitroprusside Women will be 18-55 years of age Women Estrogen Women will be 18-55 years of age
- Primary Outcome Measures
Name Time Method Magnitude of forearm blood flow Change from baseline during infusion
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie norepinephrine's effects on neurovascular function in aging women?
How does estrogen supplementation compare to standard vasodilators in improving cerebral blood flow in postmenopausal women?
Which biomarkers correlate with sympathetic nervous system activity in early vascular aging of women?
What are the potential adverse events of combined norepinephrine and isoproterenol administration in elderly female populations?
How do alpha-adrenergic and muscarinic receptors mediate drug responses in NCT06520982's neurovascular intervention?
Trial Locations
- Locations (1)
University of Missouri-Columbia
🇺🇸Columbia, Missouri, United States
University of Missouri-Columbia🇺🇸Columbia, Missouri, United StatesJacqueline K Limberg, Ph.D.Contact573-882-2420limbergj@missouri.edu